BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26677253)

  • 1. Synergy of β-Lactams with Vancomycin against Methicillin-Resistant Staphylococcus aureus: Correlation of Disk Diffusion and Checkerboard Methods.
    Sy CL; Huang TS; Chen CS; Chen YS; Tsai HC; Wann SR; Wu KS; Chen JK; Lee SS; Liu YC
    J Clin Microbiol; 2016 Mar; 54(3):565-8. PubMed ID: 26677253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
    Smith JR; Yim J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin.
    Climo MW; Patron RL; Archer GL
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1747-53. PubMed ID: 10390234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
    Miranda-Novales G; Leaños-Miranda BE; Vilchis-Pérez M; Solórzano-Santos F
    Ann Clin Microbiol Antimicrob; 2006 Oct; 5():25. PubMed ID: 17034644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vitro synergy of various β-lactams with vancomycin against methicillin-resistant Staphylococcus aureus.
    Liao CH; Chen SY; Huang YT; Tsai HY; Hsueh PR
    J Infect; 2017 Mar; 74(3):324-325. PubMed ID: 28065807
    [No Abstract]   [Full Text] [Related]  

  • 6. Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureus.
    Sharma AD; Gutheil WG
    Microbiol Spectr; 2023 Feb; 11(1):e0372622. PubMed ID: 36519895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro.
    Dilworth TJ; Sliwinski J; Ryan K; Dodd M; Mercier RC
    Antimicrob Agents Chemother; 2014; 58(2):1028-33. PubMed ID: 24277036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergism of prenylflavonoids from Morus alba root bark against clinical MRSA isolates.
    Zuo GY; Yang CX; Han J; Li YQ; Wang GC
    Phytomedicine; 2018 Jan; 39():93-99. PubMed ID: 29433688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and genotypic relatedness of methicillin resistant Staphylococcus aureus in a tertiary care hospital.
    Fomda BA; Thokar MA; Bashir G; Khan A; Kour A; Zahoor D; Ray P
    J Postgrad Med; 2014; 60(4):386-9. PubMed ID: 25370547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of synergy between beta-lactams and anti-methicillin-resistant Staphylococcus aureus agents from the standpoint of strain characteristics and binding action.
    Ono D; Yamaguchi T; Hamada M; Sonoda S; Sato A; Aoki K; Kajiwara C; Kimura S; Fujisaki M; Tojo H; Sasaki M; Murakami H; Kato K; Ishii Y; Tateda K
    J Infect Chemother; 2019 Apr; 25(4):273-280. PubMed ID: 30713034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Method-specific performance of vancomycin MIC susceptibility tests in predicting mortality of patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chang SC; Hsueh PR
    J Antimicrob Chemother; 2014 Jan; 69(1):211-8. PubMed ID: 23997017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinations of cefoxitin plus other β-lactams are synergistic in vitro against community associated methicillin-resistant Staphylococcus aureus.
    Banerjee R; Fernandez MG; Enthaler N; Graml C; Greenwood-Quaintance KE; Patel R
    Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):827-33. PubMed ID: 23340864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of sodium new houttuyfonate alone and in combination with oxacillin or netilmicin against methicillin-resistant Staphylococcus aureus.
    Lu X; Yang X; Li X; Lu Y; Ren Z; Zhao L; Hu X; Jiang J; You X
    PLoS One; 2013; 8(7):e68053. PubMed ID: 23844154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
    Zuo GY; Zhang XJ; Han J; Li YQ; Wang GC
    BMC Complement Altern Med; 2015 Dec; 15():425. PubMed ID: 26627468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA.
    Tran N; Rybak MJ
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains.
    Pereira F; Madureira AM; Sancha S; Mulhovo S; Luo X; Duarte A; Ferreira MJ
    J Ethnopharmacol; 2016 Feb; 178():180-7. PubMed ID: 26674158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.
    Rand KH; Houck HJ
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2871-5. PubMed ID: 15273094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etest versus vitek 2 vancomycin minimum inhibitory concentration testing methods for methicillin-resistant staphylococcus aureus: an antimicrobial stewardship initiative to evaluate the degree of discordance among methods at a rural tertiary hospital.
    Bloomgren BJ; Laible BR
    J Pharm Pract; 2013 Aug; 26(4):415-9. PubMed ID: 23907075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of rapid antimicrobial susceptibility test for Staphylococcus aureus by chemiluminescent assay and its application for screening of beta-lactam antibiotic induced vancomycin-resistant MRSA].
    Nagasawa Z; Nakashima Y; Oho M; Kusaba K; Manome I; Nagayama A
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2008; 19(1-2):7-15. PubMed ID: 19583457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prevalence of Vancomycin-Intermediate Staphylococcus aureus and Heterogeneous VISA Among Methicillin-Resistant Strains Isolated from Pediatric Population in a Turkish University Hospital.
    Mirza HC; Sancak B; Gür D
    Microb Drug Resist; 2015 Oct; 21(5):537-44. PubMed ID: 25919019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.